|Bid||75.50 x 7300|
|Ask||76.99 x 100|
|Day's Range||75.79 - 76.48|
|52 Week Range||69.30 - 88.21|
|PE Ratio (TTM)||15.12|
|Forward Dividend & Yield||2.00 (2.61%)|
|1y Target Est||N/A|
Home Depot says it will not be selling pumpkins in select stores in the south as it focuses on repair efforts. Yahoo Finance’s Alexis Christoforous, Andy Serwer, and Melody Hahm discuss why Home Depot competitors aren’t following suit.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting CVS. Over the last one-month, outflows of investor capital in ETFs holding CVS totaled $38.53 billion.
The massive online retailer with a reputation for disruption could be coming for the notoriously complex, opaque drug industry.
According to Wall Street analysts, Walgreen Boots Alliance (WBA) has a substantial upside. WBA stock is projected to rise 33% over the next year.
The e-commerce giant reportedly plans to make a decision before Thanksgiving on whether to enter the prescription drug market. Observers weigh in on how its potential entry could impact the landscape.
Anthem’s entry is notable in a highly concentrated industry dominated by just a few large players.
For the first nine months of fiscal 2017, Walgreens Boots Alliance’s adjusted diluted net earnings per share increased 7.7% YoY to $3.79.
"How Moats Translate into Sustainable Competitive Advantages" is a five-part moat investing education series that explores the primary sources of economic moats.
During the first nine months of 2017 (or 9M17), Walgreens Boots Alliance’s total sales increased 0.9% YoY to $89.5 billion.
Walgreens Boots Alliance (WBA) is slated to release its fiscal 4Q17 earnings on October 25. WBA's total sales are expected to reach $29.6 billion, a 4.6% increase over its fiscal 4Q16 sales.
Rite Aid Corporation (NYSE:RAD) investors certainly haven’t been faced with a shortage of things to chew on of late. The failure of Walgreen’s initial plan to outright acquire all shares of RAD stock in 2015 followed by the no-go on 2016’s revised plan to only buy 2,186 Rite Aid units — WBA is now only acquiring 1,932 of Rite Aid’s 4,560 stores — spurred mounds of investor concern, as a large cash infusion was seen as the only way to save the struggling Rite Aid Corporation. Here’s the thing: Rite Aid was in trouble, maybe even doomed, well before Walgreen’s was interested.
After shocking the grocery world with the Whole Foods purchase just a couple months ago, Amazon appears set to make another big move. Reports last week suggest that Amazon will make a final decision as to whether it joins the pharmacy space or not by Thanksgiving. The analysts at Leerink, in fact, suggest that it’s now a matter of when Amazon starts competing in pharmacy, not if.
Insurers are closing ranks around a model that brings the PBM closer to the health plan in hopes of creating a savvier buyer of prescription medicines while seeking more transparency.